We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)


Third collaboration for AvidiMab platform

Lighthouse | 20 January 2020


Increasingly in demand as partner of choice

Update | 20 January 2020


Licensing discussions with academic centre end

Lighthouse | 17 January 2020

Mereo BioPharma

Additional ASTEROID data supports progression

Lighthouse | 15 January 2020

Mereo BioPharma

Oncologie takes global licence to Navi

Lighthouse | 13 January 2020


AXL opportunities opening up

Outlook | 08 January 2020

Mereo BioPharma

Underappreciated and undervalued

Outlook | 07 January 2020


Making an impression in depression

Outlook | 07 January 2020


Second collaboration for AvidiMab platform

Lighthouse | 16 December 2019

Futura Medical

Remarkable data from pivotal trial opens new possibilities

Update | 11 December 2019
314 results found.